These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30198643)

  • 1. Computer-assisted Curie scoring for metaiodobenzylguanidine (MIBG) scans in patients with neuroblastoma.
    Sokol EA; Engelmann R; Kang W; Pinto N; Starkey A; Lai H; Nadel H; Shulkin BL; Pu Y; Appelbaum D; Yanik GA; Cohn SL; Armato SG; Volchenboum S
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27417. PubMed ID: 30198643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iodine-123 metaiodobenzylguanidine scintigraphy scoring allows prediction of outcome in patients with stage 4 neuroblastoma: results of the Cologne interscore comparison study.
    Decarolis B; Schneider C; Hero B; Simon T; Volland R; Roels F; Dietlein M; Berthold F; Schmidt M
    J Clin Oncol; 2013 Mar; 31(7):944-51. PubMed ID: 23341514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the detecting capability between
    Qiu ZL; Saito S; Kayano D; Wakabayashi H; Kinuya S
    Ann Nucl Med; 2021 Jun; 35(6):649-661. PubMed ID: 33866530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association between Tumour Markers and Meta-iodobenzylguanidine Scans in South African Children with High-risk Neuroblastoma.
    Van Heerden J; Kruger M; Esterhuizen TM; Hendricks M; Du Plessis J; Engelbrecht G; Janse van Vuuren M; van Emmenes B; Uys R; Burger C; Nyakale N; More S; Brink A
    Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):517-526. PubMed ID: 33781675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma.
    Messina JA; Cheng SC; Franc BL; Charron M; Shulkin B; To B; Maris JM; Yanik G; Hawkins RA; Matthay KK
    Pediatr Blood Cancer; 2006 Dec; 47(7):865-74. PubMed ID: 16444675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group.
    Yanik GA; Parisi MT; Shulkin BL; Naranjo A; Kreissman SG; London WB; Villablanca JG; Maris JM; Park JR; Cohn SL; McGrady P; Matthay KK
    J Nucl Med; 2013 Apr; 54(4):541-8. PubMed ID: 23440556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology Group.
    Naranjo A; Parisi MT; Shulkin BL; London WB; Matthay KK; Kreissman SG; Yanik GA
    Pediatr Blood Cancer; 2011 Jul; 56(7):1041-5. PubMed ID: 21328522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
    Papathanasiou ND; Gaze MN; Sullivan K; Aldridge M; Waddington W; Almuhaideb A; Bomanji JB
    J Nucl Med; 2011 Apr; 52(4):519-25. PubMed ID: 21421719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superiority of SPECT/CT over planar 123I-mIBG images in neuroblastoma patients with impact on Curie and SIOPEN score values.
    Černý I; Prášek J; Kašpárková H
    Nuklearmedizin; 2016 Aug; 55(4):151-7. PubMed ID: 27054367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children's Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1.
    Yanik GA; Parisi MT; Naranjo A; Nadel H; Gelfand MJ; Park JR; Ladenstein RL; Poetschger U; Boubaker A; Valteau-Couanet D; Lambert B; Castellani MR; Bar-Sever Z; Oudoux A; Kaminska A; Kreissman SG; Shulkin BL; Matthay KK
    J Nucl Med; 2018 Mar; 59(3):502-508. PubMed ID: 28887399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. I-131 MIBG post-therapy scan is more sensitive than I-123 MIBG pretherapy scan in the evaluation of metastatic neuroblastoma.
    Yang J; Codreanu I; Servaes S; Zhuang H
    Nucl Med Commun; 2012 Nov; 33(11):1134-7. PubMed ID: 22825037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performing [
    Borgwardt L; Brok J; Andersen KF; Madsen J; Gillings N; Fosbøl MØ; Denholt CL; Petersen IN; Sørensen LS; Enevoldsen LH; Oturai PS; Johannesen HH; Højgaard L; Schulze C; Saxtoft E; Andersen F; Fischer BM
    J Nucl Med; 2024 Aug; 65(8):1286-1292. PubMed ID: 38960713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma.
    Matthay KK; Edeline V; Lumbroso J; Tanguy ML; Asselain B; Zucker JM; Valteau-Couanet D; Hartmann O; Michon J
    J Clin Oncol; 2003 Jul; 21(13):2486-91. PubMed ID: 12829667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metaiodobenzylguanidine assessment of metastatic neuroblastoma: observer dependency and chemosensitivity evaluation. The SFOP Group.
    Frappaz D; Bonneu A; Chauvot P; Edeline V; Giammarile F; Siles S; Wioland M; Gomez F
    Med Pediatr Oncol; 2000 Apr; 34(4):237-41. PubMed ID: 10742058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of targeting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients.
    Hoefnagel CA; Rutgers M; Buitenhuis CK; Smets LA; de Kraker J; Meli M; Carrel F; Amstutz H; Schubiger PA; Novak-Hofer I
    Eur J Nucl Med; 2001 Mar; 28(3):359-68. PubMed ID: 11315605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of 99Tcm-sestamibi scintigraphy in the staging and prediction of the therapeutic response of stage IV neuroblastoma: comparison with 131I-MIBG and 99Tcm-MDP scintigraphy.
    Burak Z; Yüksel DA; Cetingül N; Kantar M; Ozkiliç H; Moretti JL
    Nucl Med Commun; 1999 Nov; 20(11):991-1000. PubMed ID: 10572908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
    Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent positive metaiodobenzylguanidine scans after autologous peripheral blood stem cell transplantation may indicate maturation of stage 4 neuroblastoma.
    Okamoto Y; Kodama Y; Nishikawa T; Rindiarti A; Tanabe T; Nakagawa S; Yoshioka T; Takumi K; Kaji T; Kawano Y
    Pediatr Hematol Oncol; 2017 Apr; 34(3):157-164. PubMed ID: 28976242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative localization of neuroblastoma in children with 123I- or 125I-radiolabeled metaiodobenzylguanidine.
    Martelli H; Ricard M; Larroquet M; Wioland M; Paraf F; Fabre M; Josset P; Helardot PG; Gauthier F; Terrier-Lacombe MJ; Michon J; Hartmann O; Tabone MD; Patte C; Lumbroso J; Gruner M
    Surgery; 1998 Jan; 123(1):51-7. PubMed ID: 9457223
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Aboian MS; Huang SY; Hernandez-Pampaloni M; Hawkins RA; VanBrocklin HF; Huh Y; Vo KT; Gustafson WC; Matthay KK; Seo Y
    J Nucl Med; 2021 Jan; 62(1):43-47. PubMed ID: 32414950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.